Skip to content

Laser or pulsed electromagnetic field: which treatment is more effective for knee osteoarthritis?

Laser or pulsed electromagnetic field: which modality is more effective in the treatment of knee osteoarthritis? A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN17001174
Enrollment
46
Registered
2022-04-20
Start date
2021-05-15
Completion date
Unknown
Last updated
2023-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary knee osteoarthritis Musculoskeletal Diseases Gonarthrosis [arthrosis of knee]

Interventions

Participants are randomly assigned to one of the two intervention groups by using a computer-generated random software sequence of allocation. Participants are randomized by the clinic secretary, who

Sponsors

University of Haifa
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Primary KOA 2. Age 50-75 years old 3. Both genders 4. Symptomatic knee pain lasting for 6 months or longer 5. Pain level =4 out of 10 according to the Visual Analog Scale (VAS scale) 6. Independent walking ability of at least 30 meters 7. KOA level of 2-3 according to the Kellgren–Lawrence classification scale

Exclusion criteria

Exclusion criteria: 1. Participants with secondary KOA 2. Significant sensory disturbances in the lower extremities 3. Uncontrolled diabetes or uncontrolled heart disease 4. Body Mass Index (BMI) >40 kg/m² 5. Presence of pacemaker 6. Previous surgeries in lower limbs 7. Metal or implants in the body 8. Inability to understand simple instructions

Design outcomes

Primary

MeasureTime frame
Pain intensity during rest, walking, and while standing up measured using the visual analog scale (VAS) at baseline and post the six sessions (week 3)

Secondary

MeasureTime frame
1. Pain intensity, stiffness, and level of physical functioning measured using the Hebrew version of the Western Ontario and McMaster Universities Osteoarthritis questionnaire (WOMAC) at baseline and post the six sessions (week 3) 2. Functional mobility measured using the Timed Up and Go (TUG) test at baseline and post the six sessions (week 3) 3. Walking ability measured using the 10-Meter Walk (10MW) at baseline and post the six sessions (week 3)

Countries

Israel

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 11, 2026